Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4kf1 | HT5 | Aryldialkylphosphatase | 3.1.8.1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 4kf1 | HT5 | Aryldialkylphosphatase | 3.1.8.1 | 1.000 | |
| 2fto | CB3 | Thymidylate synthase | / | 0.460 | |
| 4hw3 | 19G | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.460 | |
| 3ssn | MVI | Mycinamicin VI 2''-O-methyltransferase | / | 0.453 | |
| 3bhr | THG | Thymidylate synthase | / | 0.451 | |
| 5k2b | ZMA | Adenosine receptor A2a | / | 0.450 | |
| 3vt5 | YI2 | Vitamin D3 receptor | / | 0.449 | |
| 2j3k | NAP | NADPH-dependent oxidoreductase 2-alkenal reductase | 1.3.1.74 | 0.446 | |
| 4g1z | 0VP | Vitamin D3 receptor A | / | 0.446 | |
| 4bii | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.445 | |
| 3bgx | MEF | Thymidylate synthase | / | 0.444 | |
| 2hcd | BIV | Vitamin D3 receptor A | / | 0.443 | |
| 3vt6 | 5YI | Vitamin D3 receptor | / | 0.442 | |
| 1qbg | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.441 | |
| 4ia3 | BIV | Vitamin D3 receptor A | / | 0.441 | |
| 2j3i | NAP | NADPH-dependent oxidoreductase 2-alkenal reductase | 1.3.1.74 | 0.440 | |
| 2x9d | ITC | Tetracycline repressor protein class D | / | 0.440 | |
| 3vt7 | VDX | Vitamin D3 receptor | / | 0.440 | |
| 4hfm | NAP | 2-alkenal reductase (NADP(+)-dependent) | / | 0.440 |